Clinical trial
Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of…
NCT00233779 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00233779 |
|---|---|
| Title | Evaluation of Sirolimus-Eluting, Heparin-Coated CoCr Stent in the Treatment of de Novo Coronary Artery Lesions in Small Vessels(EVOLUTION) |
| Official title | Sirolimus-Eluting, Heparin-Coated Cobalt Chromium Balloon-Expandable Stent in the Treatment of Patients With de Novo Coronary Artery Lesions in Small Vessels (EVOLUTION) |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | SIROLIMUS-ELUTING, HEPARIN-COATED CoCr BALLOON-EXPANDABLE STENT |
| Enrollment | 52 |
| Start date | Oct 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Oct 6, 2005 |
| Last update posted | Jun 27, 2007 |
| Countries | Brazil |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: